Australia's most trusted
source of pharma news
Wednesday, 22 July 2026
Wednesday, 22 July 2026
Subscribe
Login
Redundancies cut deep in 2026
The number of companies implementing global layoffs in the first half of 2026 has dropped hugely compared to the same time last year. But organisations that have cut - have cut deep - meaning overall job losses have barely fallen.
AZ's COPD inhaler goes green
Next-generation treatment, offering 99 per cent reduction in global warming potential has touched down in Australia
TODAY
Company names new global CEO
Regional head of a major snack company to take the global reins of a pharmaceutical company, praised for his "execution excellence"
TODAY
Talent moving on... and up
As company workforces continue to change shape, hiring and promotion of top talent remains. See who's scored a new role
21 July
Who's to blame for bottlenecks?
Survey of Australian pharma professionals has lifted the lid on company bottlenecks revealing who's at fault
21 July
Another ANZ GM departs
After two-and-a-half years in the top job, this ANZ General Manager will be leaving the role at the end of the month
20 July
17 drugs eye August listing
Twelve of the 17 drugs jumped on the wait list after reaching the last stage before PBS listing occurs in June
20 July
Latest Jobs
Supply Chain CoordinatorBusiness Development Manager - Acute CareSenior Technical & Regulatory AssociateTerritory Manager - DevicesHead of Sales - Community CareHead of Unlicensed MedicinesQuality AssociateBD Lead APAC41 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (22)
- Business Development Manager - Acute Care - Melbourne
- Territory Manager - Devices - Gold Coast
- Head of Sales - Community Care - Sydney
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Sydney
- Territory Manager - Newcastle
- Medical Sales Representative - Sydney
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Customer Service Representative - Perth
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Frenchs Forest
- Territory Manager - Auckland
- Territory Manager - Melbourne
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
Access & Reimbursement (1)
Clinical & Medical, R&D (8)
- Clinical Research Associate - Sydney
- Medical Science Liaison - Sydney
- Medical Sales Representative - Sydney
- Clinical Trial Study Start Up Specialist - Melbourne
- Clinical Research Associate II - Melbourne
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
- Clinical Trial Investigator - Melbourne
Regulatory, Pharmacovigilance & QA (5)
- Senior Technical & Regulatory Associate - Sydney
- Quality Associate - Sydney
- Senior Quality Engineer - Tullamarine
- Senior Quality Assurance Associate - Randwick
- Regulatory Affairs Manager - Belrose
Devices (1)
Other (14)
- Supply Chain Coordinator - Sydney
- Head of Unlicensed Medicines - Sydney
- BD Lead APAC - Australia, Melbourne Preferred (Remote – Flexible)
- Warehouse Assistant - North Ryde
- Senior Payroll Specialist - Macquarie Park
- Distribution Clerk - Warehousing - Jacana
- Commercial Specialist - Brisbane
- Logistics Planner - North Ryde
- Warehouse Assistant - Eight Mile Plains
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
First August PBS listing goes to...
The first of 17 potential PBS contenders for August has been confirmed by the Health Department
21 July
Aussie joins the US$1 billion club
Watch this space: Strong growth puts an ASX-listed company on track for more than a billion US dollars in revenue for FY2026
21 July
Pharmas face First Nations flak
Industry in the hot seat with questions over disease awareness campaigns and sponsored events featuring women of colour
21 July
Why Lilly turned down PBS listing
PSDs have revealed the roadblock that Lilly and the PBAC could not pass in arriving at an agreement to subsidise Mounjaro for diabetes
20 July
18 drugs 'missing' from the PBS
Which drugs have been named in a new report, that blames the Govt's torturous reimbursement process for the failure to win a listing
20 July
New GM to drive market expansion
After leaving J&J, this new boss has been tasked with growing the ANZ market and she is hitting the ground running
20 July
Second generic targets $53M drug
The TGA has approved a raft of generics targeting PBS listed drugs, sponsored by six pharmaceutical companies
20 July
Who's the new Novartis Country Head?
One month after its Country President stepped down, Novartis has announced a new national leader
17 July
Ali Rossiter lands new appointment
Exactly a month after resigning from her role as Novartis ANZ boss, Rossiter says this company's work is 'personally significant'
17 July
MS drugs delisting threat ends
But it comes with a sting in the tail. The PBAC will launch a review of how the drugs are being used on the PBS to be concluded by December
17 July
New PBS patient furore brewing
The Minister has put out one fire by keeping MS drugs on the PBS but another fight is brewing over access to a different life-changing treatment
17 July
Top redundancy pain points named
Mortgage stress and fear of finding work is plaguing those who have been laid off plus the other most popular stories this week
17 July Your Week in 5 Minutes
Ex-Bayer boss joins Astellas
While a GM is yet to be announced, a Head of Sales has been named becoming the newest member of the Australian Leadership Team
17 July
Who owns the next blockbuster?
The current top-valued R&D programs could rake in combined global sales of US$50M in 2032, if successfully launched
16 July